BIOEX.ST(BIOEX.ST)
BIOEX.ST
No analyst ratings available
No analyst price targets available for BIOEX.ST
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2026E | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|---|
| Revenue Avg | $2M | $5M | $25M | $57M | $104M |
| Low | $2M | $5M | $25M | $57M | $104M |
| High | $2M | $5M | $25M | $57M | $104M |
| EBITDA Avg | $-2M | $-5M | $-25M | $-57M | $-104M |
| Low | $-2M | $-5M | $-25M | $-57M | $-104M |
| High | $-2M | $-5M | $-25M | $-57M | $-104M |
| EBIT Avg | $-2M | $-5M | $-25M | $-57M | $-104M |
| Low | $-2M | $-5M | $-25M | $-57M | $-104M |
| High | $-2M | $-5M | $-25M | $-57M | $-104M |
| Net Income Avg | $-14M | $-11M | $2M | $21M | $31M |
| Low | $-14M | $-11M | $2M | $21M | $31M |
| High | $-14M | $-11M | $2M | $21M | $31M |
| EPS Avg | $-0.35 | $-0.28 | $0.06 | $0.52 | $0.78 |
| Low | $-0.35 | $-0.28 | $0.06 | $0.52 | $0.78 |
| High | $-0.35 | $-0.28 | $0.06 | $0.52 | $0.78 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 |
|---|---|---|---|---|
| Revenue Avg | $421,000 | $773,000 | $3M | $679,000 |
| Low | $421,000 | $773,000 | $3M | $679,000 |
| High | $421,000 | $773,000 | $3M | $679,000 |
| EBITDA Avg | $-421,000 | $-773,000 | $-3M | $-679,000 |
| Low | $-421,000 | $-773,000 | $-3M | $-679,000 |
| High | $-421,000 | $-773,000 | $-3M | $-679,000 |
| EBIT Avg | $-421,000 | $-773,000 | $-3M | $-679,000 |
| Low | $-421,000 | $-773,000 | $-3M | $-679,000 |
| High | $-421,000 | $-773,000 | $-3M | $-679,000 |
| Net Income Avg | $-4M | $-4M | $-2M | $-4M |
| Low | $-4M | $-4M | $-2M | $-4M |
| High | $-4M | $-4M | $-2M | $-4M |
| EPS Avg | $-0.09 | $-0.08 | $-0.05 | $-0.08 |
| Low | $-0.09 | $-0.08 | $-0.05 | $-0.08 |
| High | $-0.09 | $-0.08 | $-0.05 | $-0.08 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |